CHOROIDEREMIA

Clinical trials for CHOROIDEREMIA explained in plain language.

Never miss a new study

Get alerted when new CHOROIDEREMIA trials appear

Sign up with your email to follow new studies for CHOROIDEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Experimental eye injection aims to restore sight in rare blindness conditions

Disease control Completed

This study tested a new drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two rare diseases that cause progressive vision loss. The main goal was to check the treatment's safety and tolerability, while also looking at…

Matched conditions: CHOROIDEREMIA

Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

CHOROIDEREMIA

Get alerted when new CHOROIDEREMIA trials appear

Experimental eye injection aims to restore sight in rare blindness conditions